Biofrontera Inc. (BFRI)
(Real Time Quote from BATS)
$1.68 USD
+0.09 (5.66%)
Updated Apr 29, 2024 01:18 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for Biofrontera Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1 | 28 | 25 | 8 | -99,999 |
Receivables | 5 | 7 | 12 | 3 | NA |
Notes Receivable | 0 | 0 | 0 | 0 | NA |
Inventories | 11 | 7 | 4 | 7 | NA |
Other Current Assets | 6 | 1 | 5 | 1 | NA |
Total Current Assets | 23 | 43 | 46 | 20 | NA |
Net Property & Equipment | 0 | 0 | 0 | 0 | NA |
Investments & Advances | 0 | 0 | 0 | 0 | NA |
Other Non-Current Assets | 0 | 3 | 3 | 0 | NA |
Deferred Charges | 0 | 0 | 0 | 0 | NA |
Intangibles | 3 | 3 | 3 | 4 | NA |
Deposits & Other Assets | 0 | 0 | 0 | 0 | NA |
Total Assets | 28 | 51 | 53 | 24 | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | NA |
Accounts Payable | 9 | 3 | 1 | 2 | NA |
Current Portion Long-Term Debt | 4 | 0 | 0 | 0 | NA |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | NA |
Accrued Expenses | 4 | 11 | 10 | 3 | NA |
Income Taxes Payable | 0 | 0 | 0 | 0 | NA |
Other Current Liabilities | 0 | 7 | 3 | 0 | NA |
Total Current Liabilities | 18 | 21 | 14 | 4 | NA |
Mortgages | 0 | 0 | 0 | 0 | NA |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | NA |
Convertible Debt | 0 | 0 | 0 | 0 | NA |
Long-Term Debt | 0 | 0 | 0 | 0 | NA |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | NA |
Other Non-Current Liabilities | 4 | 5 | 28 | 14 | NA |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | NA |
Total Liabilities | 23 | 27 | 42 | 18 | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | NA |
Common Stock (Par) | 0 | 0 | 0 | 0 | NA |
Capital Surplus | 104 | 103 | 90 | 47 | NA |
Retained Earnings | -100 | -80 | -79 | -41 | NA |
Other Equity | 0 | 0 | 0 | 0 | NA |
Treasury Stock | 0 | 0 | 0 | 0 | NA |
Total Shareholder's Equity | 5 | 24 | 11 | 6 | NA |
Total Liabilities & Shareholder's Equity | 28 | 51 | 53 | 24 | NA |
Total Common Equity | 5 | 24 | 11 | 6 | 0 |
Shares Outstanding | 1.50 | 1.30 | 0.80 | NA | NA |
Book Value Per Share | 3.19 | 18.37 | 14.18 | 0.00 | 0.00 |
Fiscal Year End for Biofrontera Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 1 | 7 | 10 | 21 |
Receivables | NA | 5 | 7 | 6 | 8 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 11 | 16 | 15 | 7 |
Other Current Assets | NA | 6 | 0 | 1 | 2 |
Total Current Assets | NA | 23 | 30 | 32 | 37 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 3 | 3 | 3 | 3 |
Deposits & Other Assets | NA | 0 | 0 | 1 | 0 |
Total Assets | NA | 28 | 34 | 37 | 42 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 9 | 9 | 6 | 2 |
Current Portion Long-Term Debt | NA | 4 | 2 | 1 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 4 | 11 | 11 | 11 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 7 | 7 | 7 |
Total Current Liabilities | NA | 18 | 29 | 25 | 20 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 3 | 4 | 4 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 23 | 33 | 30 | 25 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 104 | 104 | 104 | 104 |
Retained Earnings | NA | -100 | -103 | -97 | -87 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 5 | 1 | 7 | 17 |
Total Liabilities & Shareholder's Equity | NA | 28 | 34 | 37 | 42 |
Total Common Equity | 0 | 5 | 1 | 7 | 17 |
Shares Outstanding | 5.00 | 1.50 | 1.30 | 1.30 | 1.30 |
Book Value Per Share | 0.00 | 3.19 | 0.80 | 5.52 | 12.88 |